Description
Dihexa 10mg research compound
Dihexa is an experimental compound derived from angiotensin IV research. It was developed as a metabolically stable small molecule that potentiates hepatocyte growth factor (HGF) signalling through its receptor, c-Met.
Product details
| Compound | Dihexa (PNB-0408) |
|---|---|
| Class | Angiotensin IV-derived small molecule |
| Format | Research powder |
| Labelling | Compound name and strength on every container |
What Dihexa 10mg research has examined
- HGF/c-Met signalling: potentiation of HGF activity in cell assays.
- Synaptogenesis: dendritic spine formation in neuronal culture.
- Cognition models: rodent behavioural studies.
Research interest does not establish a proven effect in humans.
Regulatory status
Dihexa 10mg is not an approved medicine. It is supplied only as a research chemical for laboratory use.
Storage and handling
Store lyophilised vials cold, dry and away from light. Reconstitute with a suitable sterile diluent under aseptic conditions and keep solutions refrigerated. See our peptide reconstitution guide.
Related research products
GHRP-2 (Pralmorelin) 10mg · Teriparatide 10mg · Thymosin Alpha 1 RGDR · All peptides
References
For laboratory research use only. Not for human or animal consumption. Not intended to diagnose, treat, cure or prevent any disease.
Reviews
There are no reviews yet.